Artelo Biosciences, Inc. (ARTL) vs Profusa, Inc. Common Stock (PFSA)

A side-by-side comparison of Artelo Biosciences, Inc. and Profusa, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Artelo Biosciences, Inc. logo
ARTL
Artelo Biosciences, Inc.
$1M
$3.39HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Profusa, Inc. Common Stock logo
PFSA
Profusa, Inc. Common Stock
$2M
$1.68HealthcareDelayed quote: Oct 6, 2026, 3:29 PM EDT

Total return — ARTL vs PFSA

growth of $100 · dividends reinvested · last 1y
ARTL -98.6% (-98.6%/yr)PFSA -100.0% (-100.0%/yr)ARTL compounded faster over this window
Log scale — wide-divergence pair
000110100Start $1002026$1$0
ARTL PFSA

ARTL vs PFSA: by the numbers

  • •PFSA is the larger company ($2M vs $1M market cap).

Metrics side by side

Valuation

MetricARTLPFSA
P/B ratio0.26N/A

Profitability

MetricARTLPFSA
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-253.57%N/A
ROIC-219.36%N/A

Growth (annualized)

MetricARTLPFSA
Total return CAGR (5Y)-64.27%N/A

Go deeper

Full ARTL analysisFull PFSA analysisInteractive comparison tool

Dig into the metrics

Artelo Biosciences ROEProfusa, Inc. Common Stock ROEArtelo Biosciences operating marginProfusa, Inc. Common Stock operating marginArtelo Biosciences revenue growthProfusa, Inc. Common Stock revenue growthArtelo Biosciences free cash flowProfusa, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.